Your browser doesn't support javascript.
loading
Drug Survival and Immunogenicity After Switching From Remicade to Biosimilar CT-P13 in Inflammatory Bowel Disease Patients: Two-year Follow-up of a Prospective Observational Cohort Study.
Smits, Lisa J T; van Esch, Aura A J; Derikx, Lauranne A A P; Boshuizen, Ronald; de Jong, Dirk J; Drenth, Joost P H; Hoentjen, Frank.
Afiliação
  • Smits LJT; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • van Esch AAJ; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • Derikx LAAP; Inflammatory Bowel Disease Center, Department of Gastroenterology and Hepatology, Radboud university medical center, Nijmegen, The Netherlands.
  • Boshuizen R; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
  • de Jong DJ; Biologics Laboratory, Sanquin Diagnostic Services, Amsterdam, The Netherlands.
  • Drenth JPH; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
  • Hoentjen F; Department of Gastroenterology and Hepatology, Jeroen Bosch hospital, 's-Hertogenbosch, The Netherlands.
Inflamm Bowel Dis ; 25(1): 172-179, 2019 01 01.
Article em En | MEDLINE | ID: mdl-29947795
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Fármacos Gastrointestinais / Doenças Inflamatórias Intestinais / Medicamentos Biossimilares / Infliximab / Anticorpos Monoclonais Idioma: En Ano de publicação: 2019 Tipo de documento: Article